Pheochromocytoma in a patient with end-stage renal disease

被引:0
|
作者
Godfrey, JA
Rickman, OB
Williams, AW
Thompson, GB
Young, WF
机构
[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Div Pulm & Crit Care Med & Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Nephrol & Internal Med, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Div Hypertens & Internal Med, Rochester, MN 55905 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pheochromocytoma is a rare tumor. To our knowledge only 15 cases have been reported in patients with end-stage renal disease (ESRD). We describe a 46-year-old woman with ESRD and a history of paroxysmal and difficult-to-control hypertension. During anesthesia for a surgical procedure, the patient experienced blood pressure lability with systolic blood pressures ranging from 76 to 360 nun Hg. Serum catecholamine concentrations were 2698 pg/mL (reference value, < 750 pg/mL) for norepinephrine, 33 pg/mL (< 110 pg/mL) for epinephrine, and 55 pg/mL (< 30 pg/mL) for dopamine. The concentrations of plasma metanephrines were 6.84 nmot/L (<0.50 nmol/L) for metanephrine and 14.64 nmol/L (<0.90 nmol/L) for normetanephrine. Abdominal computed tomography showed a right-sided, 4-cm mass posterior to the infrahepatic inferior vena cava. Following blood pressure control with alpha- and beta -adrenergic blockade, the mass was removed. Pathologic examination demonstrated the mass was a pheochromocytoma. The maximum postoperative systolic blood pressure was 160 mm Hg. Postoperative plasma normetanephrine concentration was 2.80 nmol/L, and metanephrine was obscured by interfering substances. This case report and literature review emphasizes the difficulty in diagnosing pheochromocytomas in patients with ESRD despite the myriad of available diagnostic tests.
引用
收藏
页码:953 / 957
页数:5
相关论文
共 50 条
  • [21] LIFE-CYCLE OF THE END-STAGE RENAL-DISEASE PATIENT - TOWARDS A DEVELOPMENTAL VIEW OF END-STAGE RENAL-DISEASE
    KIMMEL, PL
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (03) : 191 - 193
  • [22] Misdiagnosis of Addison's Disease in a Patient with End-Stage Renal Disease
    Kocyigit, Ismail
    Unal, Aydin
    Tanriverdi, Fatih
    Sipahioglu, Murat Hayri
    Tokgoz, Bulent
    Oymak, Oktay
    Utas, Cengiz
    RENAL FAILURE, 2011, 33 (01) : 88 - 91
  • [23] Optimal dialysis for the end-stage renal disease patient with cardiovascular disease
    Dumler, F
    McCullough, PA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (03) : 261 - 273
  • [24] Delivery of Radioiodine Ablation in a Patient with End-Stage Renal Disease
    Bussey, Andrew T.
    Tin, Aung
    Hoye, Neil
    Richardson, Mark
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2022, 21 (04) : 320 - 324
  • [25] EMOTIONAL SUPPORT OF THE PATIENT WITH END-STAGE RENAL-DISEASE
    GEYER, N
    SOUTH AFRICAN JOURNAL OF SURGERY, 1979, 17 (03) : 117 - 117
  • [26] End-stage renal disease in a patient with congenital lymphangiectasia and lymphedema
    Kostas I. Sombolos
    Aristea I. Papachillea
    Taisir M. Natse
    Kostas I. Gogos
    Georgios O. Pavlidis
    Kostas A. Barboutis
    Kostas S. Mavromatidis
    Pediatric Nephrology, 2001, 16 : 151 - 153
  • [27] HEMODIALYSIS IN THE DIABETIC PATIENT WITH END-STAGE RENAL-DISEASE
    LEEHEY, DJ
    RENAL FAILURE, 1994, 16 (05) : 547 - 553
  • [28] URINE TROUBLE: NEPHROLITHIASIS IN AN END-STAGE RENAL DISEASE PATIENT
    Hasnie, Ammar
    Kahn, Mauricio
    Centor, Robert M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S362 - S362
  • [29] Neutropenia due to clopidogrel in a patient with end-stage renal disease
    Akcay, A
    Kanbay, M
    Agca, E
    Sezer, S
    Ozdemir, FN
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (09) : 1538 - 1539
  • [30] End-stage renal disease in a patient with Werner's syndrome
    Nishihara, G
    Nakamoto, M
    Yasunaga, C
    Takeda, K
    Matsuo, K
    Urabe, M
    Goya, T
    Sakemi, T
    NEPHRON, 1997, 76 (03): : 360 - 360